生命科学资讯

NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable

Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1

Amgen advances toward lupus redemption while gastric cancer candidate struggles

HHS launches $100M antiviral prize to develop broad-spectrum therapies

NIH turmoil takes center stage as director acknowledges no vaccine-autism link

Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges

Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

Charles River to close cell therapy CDMO site, lay off 20 staffers

Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b

NMD flunks rare disease trial but flexes secondary data to accelerate program

Quest launches residual disease blood test for multiple myeloma

How Mirum is Advancing Rare Disease Care Through Strategic M&A

Novo’s CagriSema tops semaglutide in ph. 3 diabetes study

GSK gives back rights to Wave's genetic disease RNA editor

Thermo Fisher trims Massachusetts headcount with Franklin site closure

GSK plans to lay off up to 350 R&D workers across US, UK

Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health

Roche's return to RNA continues with $1.7B deal for Sanegene program

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative